Supplementary Table S1 from Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma
收藏数据链接:
官方服务:
资源简介:
All antibodies used were listed in Table S1.
创建时间:
2025-11-14

All antibodies used were listed in Table S1.